These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 2-Acetylaminofluorene-mediated alteration in the level of liver arylsulfotransferase IV during rat hepatocarcinogenesis. Ringer DP; Norton TR; Howell BA Cancer Res; 1990 Sep; 50(17):5301-7. PubMed ID: 2386938 [TBL] [Abstract][Full Text] [Related]
3. Reaction product inactivation of aryl sulfotransferase IV following electrophilic substitution by the sulfuric acid ester of N-hydroxy-2-acetylaminofluorene. Ringer DP; Norton TR; Self RR Carcinogenesis; 1992 Jan; 13(1):107-12. PubMed ID: 1733562 [TBL] [Abstract][Full Text] [Related]
4. Molecular cloning, expression, and characterization of novel human SULT1C sulfotransferases that catalyze the sulfonation of N-hydroxy-2-acetylaminofluorene. Sakakibara Y; Yanagisawa K; Katafuchi J; Ringer DP; Takami Y; Nakayama T; Suiko M; Liu MC J Biol Chem; 1998 Dec; 273(51):33929-35. PubMed ID: 9852044 [TBL] [Abstract][Full Text] [Related]
5. Characterization of a complementary DNA for rat liver aryl sulfotransferase IV and use in evaluating the hepatic gene transcript levels of rats at various stages of 2-acetylaminofluorene-induced hepatocarcinogenesis. Yerokun T; Etheredge JL; Norton TR; Carter HA; Chung KH; Birckbichler PJ; Ringer DP Cancer Res; 1992 Sep; 52(17):4779-86. PubMed ID: 1511441 [TBL] [Abstract][Full Text] [Related]
6. Sulphonation of N-hydroxy-2-acetylaminofluorene by human dehydroepiandrosterone sulphotransferase. Lewis AJ; Otake Y; Walle UK; Walle T Xenobiotica; 2000 Mar; 30(3):253-61. PubMed ID: 10752640 [TBL] [Abstract][Full Text] [Related]
7. Self-catalyzed irreversible inactivation of rat hepatic aryl sulfotransferase IV by N-hydroxy-2-acetylaminofluorene. Mangold BL; Erickson J; Lohr C; McCann DJ; Mangold JB Carcinogenesis; 1990 Sep; 11(9):1563-7. PubMed ID: 2401045 [TBL] [Abstract][Full Text] [Related]
8. Evidence of two separate mechanisms for the decrease in aryl sulfotransferase activity in rat liver during early stages of 2-acetylaminofluorene-induced hepatocarcinogenesis. Ringer DP; Howell BA; Norton TR; Woulfe GW; Duffel MW; Kosanke SD Mol Carcinog; 1994 Jan; 9(1):2-9. PubMed ID: 8297481 [TBL] [Abstract][Full Text] [Related]
9. Isolation and expression of a cDNA encoding a male-specific rat sulfotransferase that catalyzes activation of N-hydroxy-2-acetylaminofluorene. Nagata K; Ozawa S; Miyata M; Shimada M; Gong DW; Yamazoe Y; Kato R J Biol Chem; 1993 Nov; 268(33):24720-5. PubMed ID: 8227031 [TBL] [Abstract][Full Text] [Related]
10. Sulfation of carcinogenic aromatic hydroxylamines and hydroxamic acids by rat and human sulfotransferases: substrate specificity, developmental aspects and sex differences. Meerman JH; Ringer DP; Coughtrie MW; Bamforth KJ; Gilissen RA Chem Biol Interact; 1994 Jun; 92(1-3):321-8. PubMed ID: 8033265 [TBL] [Abstract][Full Text] [Related]
11. Sulfation of aromatic hydroxamic acids and hydroxylamines by multiple forms of human liver sulfotransferases. Gilissen RA; Bamforth KJ; Stavenuiter JF; Coughtrie MW; Meerman JH Carcinogenesis; 1994 Jan; 15(1):39-45. PubMed ID: 8293546 [TBL] [Abstract][Full Text] [Related]
12. Catalytic effect of serum albumin on the o-rearrangement of N-sulfooxy-2-acetylaminofluorene, a potential hepatocarcinogen in the rat, to nonmutagenic sulfuric acid esters of o-amidofluorenols. Smith BA; Gutmann HR; Springfield JR Biochem Pharmacol; 1989 Nov; 38(22):3987-94. PubMed ID: 2597180 [TBL] [Abstract][Full Text] [Related]
13. Sulfation of di- and tricyclic phenols by rat liver aryl sulfotransferase isozymes. Parker MH; McCann DJ; Mangold JB Arch Biochem Biophys; 1994 May; 310(2):325-31. PubMed ID: 8179315 [TBL] [Abstract][Full Text] [Related]
14. Purification, immunochemical characterization, and immunohistochemical localization of rat hepatic aryl sulfotransferase IV. Duffel MW; Binder TP; Hosie L; Baden HA; Sanders JA; Knapp SA; Baron J Mol Pharmacol; 1991 Jul; 40(1):36-44. PubMed ID: 1857339 [TBL] [Abstract][Full Text] [Related]
15. Sulfation of hydroxylamines and hydroxamic acids in liver cytosol from male and female rats and purified aryl sulfotransferase IV. Gilissen RA; Ringer DP; Stavenuiter HJ; Mulder GJ; Meerman JH Carcinogenesis; 1992 Oct; 13(10):1699-703. PubMed ID: 1423828 [TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of hepatic and intestinal phenol sulfotransferase with high affinity for benzo[a]pyrene phenols from channel catfish, Ictalurus punctatus. Tong Z; James MO Arch Biochem Biophys; 2000 Apr; 376(2):409-19. PubMed ID: 10775429 [TBL] [Abstract][Full Text] [Related]
17. Changes in rat liver N-hydroxy-2-acetylaminofluorene aryl sulfotransferase activity at early and late stages of hepatocarcinogenesis resulting from dietary administration of 2-acetylaminofluorene. Ringer DP; Norton TR; Cox B; Howell BA Cancer Lett; 1988 Jun; 40(3):247-55. PubMed ID: 3164251 [TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of N-hydroxy-2-acetylaminofluorene sulfotransferase from rat liver. Wu SG; Straub KD J Biol Chem; 1976 Nov; 251(21):6529-36. PubMed ID: 10300 [TBL] [Abstract][Full Text] [Related]
19. Effect of glutathione depletion on the hepatotoxicity and covalent binding rat liver macromolecules of N-hydroxy-2-acetylaminofluorene. Meerman JH; Tijdens RB Cancer Res; 1985 Mar; 45(3):1132-9. PubMed ID: 2578873 [TBL] [Abstract][Full Text] [Related]
20. N-sulfoöxy-2-aminofluorene is the major ultimate electrophilic and carcinogenic metabolite of N-hydroxy-2-acetylaminofluorene in the livers of infant male C57BL/6J x C3H/HeJ F1 (B6C3F1) mice. Lai CC; Miller JA; Miller EC; Liem A Carcinogenesis; 1985 Jul; 6(7):1037-45. PubMed ID: 3860305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]